Dietary Supplement Innovation Act
The Dietary Supplement Innovation Act aims to amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework for dietary supplements, particularly concerning drug preclusion. It outlines conditions under which drugs can be added to dietary supplements and provides mechanisms for judicial review of regulatory actions. The bill focuses on consumer access and innovation in dietary supplements.
The letter, score, and explanation above are free. The point-by-point breakdown of all eight scored criteria — with each criterion's value and how it moved the grade — is a Quiet Ledger research capability.
Access options →| Date | Time | Action |
|---|---|---|
| 2026-09-10 | — | Referred to the House Committee on Energy and Commerce. |
| 2026-09-10 | — | Introduced in House |
| 2026-09-10 | — | Introduced in House |
- Methodology
- full_text_v3
- Calculated
- 2026-09-18 17:01:58.493+00
- Source version
- 2026-09-10
- Assessments
- —
The Quiet Ledger grades legislation on its content. A bill grade is analysis of the bill — not a grade of its sponsor or of any member who voted on it.